$357 Million is the total value of Foresite Capital Management IV, LLC's 9 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | $108,903,000 | -36.5% | 9,671,643 | 0.0% | 30.47% | -13.6% | |
| LYEL | Lyell Immunopharma, Inc. | $67,075,000 | -34.8% | 13,282,181 | 0.0% | 18.76% | -11.3% | |
| PHVS | Pharvaris N.V. | $59,155,000 | +26.0% | 3,261,926 | 0.0% | 16.55% | +71.4% | |
| ACRS | Sell | Aclaris Therapeutics, Inc. | $49,979,000 | +1.1% | 2,899,034 | -14.7% | 13.98% | +37.5% |
| KURA | Kura Oncology, Inc. | $29,747,000 | +14.9% | 1,849,947 | 0.0% | 8.32% | +56.2% | |
| QSI | Quantum-Si Incorporated | $20,890,000 | -40.5% | 4,463,619 | 0.0% | 5.84% | -19.1% | |
| NRIX | Sell | Nurix Therapeutics, Inc. | $14,441,000 | -58.6% | 1,030,798 | -14.5% | 4.04% | -43.7% |
| CBAY | Cymabay Therapeutics, Inc. | $5,558,000 | -8.0% | 1,787,094 | 0.0% | 1.56% | +25.1% | |
| Sell | Cue Health Inc. | $1,700,000 | -87.4% | 263,578 | -73.8% | 0.48% | -82.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 23 | Q3 2023 | 14.8% |
| Aclaris Therapeutics, Inc. | 18 | Q3 2023 | 18.9% |
| Kura Oncology, Inc. | 16 | Q3 2023 | 11.7% |
| Kinnate Biopharma Inc. | 12 | Q3 2023 | 41.8% |
| Myokardia, Inc. | 12 | Q3 2020 | 17.8% |
| Pharvaris N.V. | 11 | Q3 2023 | 43.4% |
| Cytokinetics Incorporated | 11 | Q2 2021 | 31.6% |
| Lyell Immunopharma, Inc. | 10 | Q3 2023 | 29.2% |
| Insmed Incorporated | 10 | Q1 2020 | 19.2% |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | Q1 2020 | 14.5% |
View Foresite Capital Management IV, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-05 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 4 | 2023-05-10 |
| 4 | 2023-02-22 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
View Foresite Capital Management IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.